Involvement of MrgprC in Electroacupuncture Analgesia for Attenuating CFA-Induced Thermal Hyperalgesia by Suppressing the TRPV1 Pathway

Abstract EN

Mas-related G-protein-coupled receptor C (MrgprC) plays an important role in modulating chronic inflammatory pain.

Electroacupuncture (EA) has a satisfactory analgesic effect on chronic pain.

This study aimed to investigate the involvement of MrgprC and its transient receptor potential vanilloid 1 (TRPV1) pathway in EA analgesia in chronic inflammatory pain.

Chronic inflammatory pain was induced by subcutaneously injecting complete Freund’s adjuvant (CFA) into the left hind paw.

EA (2/100 Hz) stimulation was administered.

MrgprC siRNAs were intrathecally administered to inhibit MrgprC expression, and bovine adrenal medulla 8-22 (BAM8-22) was used to activate MrgprC.

The mechanical allodynia was decreased by EA significantly since day 3.

The piled analgesic effect of EA was partially blocked by 6 intrathecal administrations of MrgprC siRNA.

Both EA and BAM8-22 could downregulate the expression of TRPV1 and PKC in both the DRG and the SCDH.

Both EA and BAM8-22 could also decrease the TRPV1 translocation and p-TRPV1 level in both the DRG and the SCDH.

The effects of EA on PKCε, TRPV1 translocation, and p-TRPV1 in both the DRG and the SCDH were reversed by MrgprC siRNA.

The results indicated that MrgprC played crucial roles in chronic pain modulation and was involved in EA analgesia partially through the regulation of TRPV1 function at the DRG and SCDH levels.